Show simple item record

dc.creatorLitterio, Nicolás Javier
dc.creatorLorenzutti, Augusto Matías
dc.creatorZarazaga, María del Pilar
dc.creatorHimelfarb, Martín Alejandro
dc.creatorSan Andrés-Larrea, Manuel Ignacio
dc.creatorSerrano-Rodríguez, Juan Manuel
dc.date2021-01
dc.date.accessioned2023-04-10T17:50:00Z
dc.date.available2023-04-10T17:50:00Z
dc.identifierhttp://pa.bibdigital.ucc.edu.ar/3433/1/A_Litterio_Lorenzutti_Zarazaga.pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12032/85886
dc.descriptionCefquinome is a fourth-generation cephalosporin that is used empirically in goats. Different physiologic factors like pregnancy or lactation could determine the pharmacokinetic behavior of drugs in the organism. The objectives of this study are to (a) compare the pharmacokinetics of cefquinome after intravenous and intramuscular administration in adult nonpregnant (n = 6), pregnant (n = 6), and lactating goats (n = 6), at a dose of 2 mg/kg, with rich sampling by nonlinear mixed-effects modeling, (b) conduct a pharmacokinetic/pharmacodynamic analysis to evaluate the efficacy of the recommended posology in goats with different physiological states, and (c) determine the optimal posology that achieve a PTA value ≥ 90%, taking into account a T > MIC ≥ 60% of a MIC value ≤ 0.25 µg/ml, in the different subpopulations of goats for both routes. Gestation significantly increased Ka and V1, while reduced F0, Cl, and Q. On the other hand, lactation significantly increased V1 and reduced Tk0. Cefquinome concentrations achieved in placental cotyledon, amniotic fluid, and fetal serum indicate a minimal penetration across the placental barrier. Moreover, milk penetration of cefquinome was minimal. The total body clearance of cefquinome for goats was 0.29 L kg−1 hr−1, that is apparently higher than the reported for cows (0.13 L kg−1 hr−1) and pigs (0.16 L kg−1 hr−1). So, the optimal dose regimen for cefquinome after intravenous and intramuscular administration required higher dose and frequency of administration compared with recommendations for cows or pigs. Therefore, 2 mg kg−1 8 hr−1 and 5 mg kg−1 12 hr−1 could be used for IV and IM routes, respectively, for the treatment of respiratory infections caused by P. multocida and M. haemolytica, but only 5 mg kg−1 12 hr−1 by both routes should be recommended for Escherichia coli infections.
dc.descriptionFil: Litterio, Nicolás Javier. Universidad Católica de Córdoba. IRNASUS CONICET. Facultad de Ciencias Agropecuarias; Argentina
dc.descriptionFil: Lorenzutti, Augusto Matías. Universidad Católica de Córdoba. IRNASUS CONICET. Facultad de Ciencias Agropecuarias; Argentina
dc.descriptionFil: Zarazaga, María del Pilar. Universidad Católica de Córdoba. IRNASUS CONICET. Facultad de Ciencias Agropecuarias; Argentina
dc.descriptionFil: Himelfarb, Martín Alejandro. Universidad Católica de Córdoba. IRNASUS CONICET. Facultad de Ciencias Agropecuarias; Argentina
dc.descriptionFil: San Andrés-Larrea, Manuel Ignacio. Universidad Complutense de Madrid. Faculty of Veterinary Medicine. Department of Pharmacology and toxicology; España
dc.descriptionFil: Serrano-Rodríguez, Juan Manuel. Universidad de Córdoba. Faculty of Veterinary Medicine. Pharmacology Area. Department of Nursing, Pharmacology and Physiotherapy; España
dc.formatapplication/pdf
dc.languagespa
dc.publisherBlackwell Publishing Ltd
dc.relationhttp://pa.bibdigital.ucc.edu.ar/3433/
dc.relationhttps://www.scopus.com/redirect/linking.uri?targetURL=https%3a%2f%2fdoi.org%2f10.1111%2fjvp.12900&locationID=1&categoryID=4&eid=2-s2.0-85089175853&issn=01407783&linkType=ViewAtPublisher&year=2021&origin=recordpage&dig=b2da6d8305d4ba5cb89475a1b8451532
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/10.1111/jvp.12900
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.sourceLitterio, Nicolás Javier ORCID: https://orcid.org/0000-0002-8114-0579 <https://orcid.org/0000-0002-8114-0579>, Lorenzutti, Augusto Matías ORCID: https://orcid.org/0000-0002-9799-4499 <https://orcid.org/0000-0002-9799-4499>, Zarazaga, María del Pilar ORCID: https://orcid.org/0000-0001-6195-7744 <https://orcid.org/0000-0001-6195-7744>, Himelfarb, Martín Alejandro ORCID: https://orcid.org/0000-0001-7190-1103 <https://orcid.org/0000-0001-7190-1103>, San Andrés-Larrea, Manuel Ignacio ORCID: https://orcid.org/0000-0003-1829-6113 <https://orcid.org/0000-0003-1829-6113> and Serrano-Rodríguez, Juan Manuel ORCID: https://orcid.org/0000-0001-5817-5514 <https://orcid.org/0000-0001-5817-5514> (2021) Comparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed-effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 44 (1). ISSN 0140-7783
dc.subjectQL Zoología
dc.titleComparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed-effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramuscular administration
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record


© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP